Market revenue in 2023 | USD 15.8 million |
Market revenue in 2030 | USD 22.4 million |
Growth rate | 5.1% (CAGR from 2023 to 2030) |
Largest segment | Carbohydrates |
Fastest growing segment | Carbohydrates |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Ethers & Carboxylic Acids, Other Chemical Natures |
Key market players worldwide | Basf SE, Lonza Group Ltd, Evonik Industries AG, Roquette America, JRS Pharma, Micro Powders, Fumeipharm, Cristalco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plant-based excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 20.89% in 2023. Horizon Databook has segmented the Saudi Arabia plant-based excipients market based on carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, ethers & carboxylic acids, other chemical natures covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia has the largest pharmaceutical market in the region. It has the largest economy in the Gulf Cooperation Council (GCC) in terms of population as well as Gross Domestic Product (GDP). The pharmaceutical industry in Saudi Arabia is primarily reliant on medicines imported from the U.S., Europe, China, and India.
Only 30% of medications sold in Saudi Arabia are manufactured locally. The government is encouraging investment in pharmaceutical production to manufacture at least 40% of the total drugs in the Saudi market as a result of the low level of pharmaceutical production.
Saudi Arabia has the highest pharmaceutical sales in the Middle East and North Africa (MENA) region over Egypt, Morocco, and the UAE. All these factors are expected to improve the demand for pharmaceutical excipients and support the market in Saudi Arabia.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia plant-based excipients market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia plant-based excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account